Physician profile
William David Stembridge
NPI 1801159876
$1,465.73
in general payments reported to CMS, 2019-2025
13 companies · $84.37 in 2025
The $84.37 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $774 · 2021: $33.35 · 2022: $73.05 · 2023: $77.41 · 2024: $18.30 · 2025: $84.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $774.29 | 2020 | |
| Intuitive Surgical, INC. | $190.41 | 2019-2022 | |
| Medtronic Vascular, INC. | $180.75 | 2019 | |
| Amarin Pharma, INC. | $94.71 | 2019-2021 | |
| Baxter Healthcare | $47.19 | 2023 | |
| Boston Scientific Corporation | $34.52 | 2025 | Spyglass Discover, Orcapod |
| Pacira Pharmaceuticals Incorporated | $30.22 | 2023 | Exparel |
| Karl Storz Endoscopy-America | $30.21 | 2022 | |
| Ucb, INC. | $18.30 | 2024 | Cimzia |
| Solventum Corporation | $17.90 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Organogenesis INC. | $16.66 | 2025 | Via Matrix |
| Conmed Corporation | $15.29 | 2025 | Airseal |
| Gilead Sciences, INC. | $15.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Stembridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.